| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |